"There were so many conflicting reports about Vitamin E and its effect on various diseases, particularly heart disease, that we wanted to set the record straight, says Prof. Dov Lichtenberg of Tel Aviv University’s Sackler School of Medicine.
Sunday, January 31, 2010
Vitamin E supplements do more harm
"There were so many conflicting reports about Vitamin E and its effect on various diseases, particularly heart disease, that we wanted to set the record straight, says Prof. Dov Lichtenberg of Tel Aviv University’s Sackler School of Medicine.
Tuesday, January 26, 2010
Thursday, January 14, 2010
Happy Uttarayan from Gujarat
Happy Uttarayan to All
from Dhirendra from Gujarat.
May this 2010 1st feastival
bring Happiness to your life.
I wish you and your family a very
Happy Makar Sankranthi.
Sunday, January 10, 2010
Calcium vital to tickle our taste buds
Good morning friends. A new study has shown that calcium plays a vital role in tickling our taste buds.
The team of Japanese researchers have shown that calcium channels on the tongue are the targets of compounds that can enhance taste. Kokumi taste foods contain various compounds that have no taste themselves, but can enhance the basic sweet, salty and umami taste sensation they co-exist with. Lead researcher Yuzuru Eto examined whether calcium channels- which sense and regulate the levels of calcium in the body- might be the mechanism involved.
They found that calcium channels are closely related to the receptors that sense sweet and umami (savory) tastes and that glutathione (a common kokumi taste element) is known to interact with calcium channels. During the study, researchers created several small molecules that resembled glutathione and analyzed how well these compounds activated calcium channels in cell samples.
They diluted the same test substances in flavored water (salt water, sugar water, etc.) and asked volunteers (all trained in discriminating tastes) to rate how strong the flavors were. The findings revealed that the molecules induced the largest activity in calcium receptors and also elicited the strongest flavor enhancement in the taste tests. The research tested several other known calcium channel activators, including calcium, and found all exhibited some degree of flavor enhancement, while a synthetic calcium channel blocker could suppress flavors. The Times of India
Thursday, December 31, 2009
Greetings on New Years Day
Happy new Year!
Monday, December 21, 2009
3 easy ways to soothe stiff joints
Tuesday, December 15, 2009
Steroid jabs delay diabetic retinopathy
Good morning friends. A new study has revealed that injecting steroids into the eye can significantly reduce progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness.
Proliferative diabetic retinopathy occurs when new blood vessels form on the optic disc or another component of the retina. Controlling blood glucose levels can help prevent the development of retinopathy and laser treatments can reduce the risk of vision loss, but the identification of other treatments remains desirable.
The researchers showed that steroid injections interfered with the creation of new blood vessels, possibly by reducing the production of compounds that spur their growth.
During the study, lead researcher Dr Neil M. Bressler, of Johns Hopkins University School of Medicine, Baltimore analyzed 840 eyes of 693 participants who had macular edema, a leakage of fluid into part of the retina that occurs in many cases of retinopathy.
Eyes were randomly assigned to receive one of three treatments: photocoagulation (a laser treatment that destroys blood vessels) or a 1-milligram or 4-milligram injection of triamcinolone acetonide directly into the eye as often as every four months.
After two years, the research team found that retinopathy had progressed in 31 percent of 330 eyes treated with photocoagulation, 29 percent of 256 eyes treated with 1-milligram doses of triamcinolone acetonide and 21 percent of 254 eyes treated with 4-milligram doses.
These differences appeared to be sustained at three years. "Use of this intravitreal [injected into the eye] corticosteroid preparation to reduce the likelihood of progression of retinopathy is not warranted at this time because of the increased risk of glaucoma and cataract associated with intravitreal steroid use," the authors write.
"Any treatment to be used routinely to prevent proliferative diabetic retinopathy likely needs to be relatively safe because the condition already can be treated successfully and safely with panretinal photocoagulation.
“Nevertheless, further investigation with regard to the role of pharmacotherapy for reduction of the incidence of progression of retinopathy appears to be warranted," they added. – The Times of India
The study appears in journal Archives of Ophthalmology, one of the JAMA/Archives journals.